On Tuesday, Merck ( MRK -1.56%) wasn't one of the better-performing pharmaceutical stocks. In contrast to certain peers, the company's share price declined following the release of second-quarter ...

Investors were clearly impressed by the company's second-quarter beats, especially the one on the bottom line.

FDA’s latest whitepaper shows how scalable quality management investments in pharma reduce costs, improve reliability, and ...

Novo Nordisk A/S stock dips after 2025 guidance cut. However, click for why NVO's strong GLP-1 prospects, growing pipeline, ...

The stock now trades at one of its lowest price-to-earnings ratios in years. The Danish pharmaceutical giant announced it was ...

Consumers are already stretched thin, so rate cuts may not significantly boost spending or spark runaway inflation as many fear. Click for more on U.S. Economy.

Dan O'Toole, Arrive AI But this isn't just about the box-it's about orchestrating a frictionless, asynchronous delivery experience between ...

"The Mounjaro (tirzepatide) Patient Information Leaflet warns that hair loss is a common side effect in patients treated with ...

Data shows that among the largest and most influential companies on the Nasdaq, Nvidia stands out with an exceptional operating margin of 59.86%, outperforming technology giants Meta Platforms (44.42% ...

Novo Nordisk stock took a big hit early Tuesday after the Danish weight-loss drugmaker unexpectedly cut its full-year guidance for the U.S.It also announced a new CEO, appointing an insider to lead ...

Merck & Co. Inc. (NYSE:MRK) shares fell over 6% in early trading Tuesday after the pharmaceutical giant reported a mixed ...

The 15 percent tariff rate agreed under the new deal could significantly impact pharma firms reliant on European imports.